The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

26 articles for A Casimiro-Garcia


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.EBI
Pfizer
Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists.EBI
Pfizer
Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿.EBI
Pfizer
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿.EBI
Pfizer
Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action.EBI
Pfizer
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex.EBI
University of Toronto
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1.EBI
Pfizer
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.EBI
Pfizer
Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine Methyltransferase.EBI
Pfizer
Synthesis of a non-nucleoside reverse transcriptase inhibitor in the alkenyldiarylmethane (ADAM) series with optimized potency and therapeutic index.EBI
Purdue University
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans.EBI
Pfizer
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.EBI
Pfizer
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists.EBI
Pfizer
BIFUNCTIONAL FOLATE RECEPTOR BINDING COMPOUNDSBDB
Lycia Therapeutics
COMPOUNDS AND METHODS FOR MODULATING FXRBDB
Terns Pharmaceuticals
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibitionBDB
Optikira
Inhibitors of bruton's tyrosine kinaseBDB
Hoffmann-La Roche
Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabeticsBDB
King Abdulaziz University
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activityBDB
Boehringer Ingelheim International
bis-Pyridazine compounds and their use in treating cancerBDB
Astrazeneca
Substituted acethydrazide derivative, preparation method and use thereofBDB
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
Toll-like receptor 2-agonistic lipopeptides, and method of making the sameBDB
University of Kansas
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compoundsBDB
Array Biopharma
Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.BDB
National Tsing Hua University
Overview of the SAMPL5 host-guest challenge: Are we doing better?BDB
University of California San Diego
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.BDB
Glaxosmithkline